Clinical Trial: AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile Illness

U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07205575) titled 'AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile Illness' on Sept. 15.

Brief Summary: This study is a proteomics-based diagnostic biomarker study conducted on the same patient cohort as the transcriptomic biomarker study (NCT065529754). Although both studies share the same clinical cohort and overarching diagnostic aim, they are registered separately because they employ distinct omics technologies, investigate different biomarker modalities, and yield independent outcome measures.

Study Start Date: Sept. 01, 2021

Study Type: OBSERVATIONAL

Condition: Acute Febrile Illness Bact...